Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity

Conditions:   Metabolism and Nutrition Disorder;   Obesity
Interventions:   Drug: NNC9204-1706 A;   Drug: Placebo
Sponsor:   Novo Nordisk A/S
Recruiting - verified March 2017

http://ift.tt/2ocHrgd